Showing results (301-310 of 403) with videos related to

Sort By:
Pageof 41
Proceedings of the National Academy of Sciences of the United States of America|January 11, 2012
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosisMarisa Benagiano, Fabio Munari, Alessandra Ciervo, et al.
Critical Reviews in Oncology/Hematology|August 12, 2018
Clinical and circulating biomarkers of survival and recurrence after radiofrequency ablation in patients with hepatocellular carcinomaMatteo Canale, Paola Ulivi, Francesco Giuseppe Foschi, et al.
Molecular Neurobiology|May 21, 2026
Mild Cognitive Impairment Associated with Obstructive Sleep Apnoea: A Pilot Study on Oxygen-Related Plasma Biomarkers and Network AnalysisMartina De Felice, Alessia Pascazio, Rebecca Piccarducci, et al.
Frontiers in Public Health|February 26, 2025
Universal capillary screening for chronic autoimmune, metabolic and cardiovascular diseases: feasibility and acceptability of the UNISCREEN studySara Angiulli, Aurora Merolla, Elisa Borgonovo, et al.
International Journal of Molecular Sciences|January 7, 2015
Gene mutation analysis in EGFR wild type NSCLC responsive to erlotinib: are there features to guide patient selection?Paola Ulivi, Angelo Delmonte, Elisa Chiadini, et al.
Journal of Clinical Medicine|April 11, 2020
Concomitant TP53 Mutation Confers Worse Prognosis in EGFR-Mutated Non-Small Cell Lung Cancer Patients Treated with TKIsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.
Ebiomedicine|May 4, 2019
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from bloodMichela Notarangelo, Chiara Zucal, Angelika Modelska, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Impact of TP53 Mutations on Outcome in EGFR-Mutated Patients Treated with First-Line Tyrosine Kinase InhibitorsMatteo Canale, Elisabetta Petracci, Angelo Delmonte, et al.
Pageof 41